General Information of the Compound
Compound ID
CP0404851
Compound Name
[(1R)-1-[(3S,6S,9S,12S,15S)-3-carbamoyl-9-(hydroxymethyl)-12-(1H-imidazol-5-ylmethyl)-19-[2-(1H-indol-3-yl)ethyl]-15-(2-methylpropyl)-5,8,11,14,17,20-hexaoxo-1-thia-4,7,10,13,16,19-hexazacyclohenicos-6-yl]ethyl] dihydrogen phosphate
    Show/Hide
Structure
Formula
C36H51N10O12PS
Molecular Weight
878.903
Canonical SMILES
CC(C)C[C@@H]1NC(=O)CN(CCc2c[nH]c3ccccc23)C(=O)CSC[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)[C@@H](C)OP(O)(O)=O)C(N)=O
    Show/Hide
InChI
InChI=1S/C36H51N10O12PS/c1-19(2)10-25-33(51)42-26(11-22-13-38-18-40-22)34(52)43-27(15-47)35(53)45-31(20(3)58-59(55,56)57)36(54)44-28(32(37)50)16-60-17-30(49)46(14-29(48)41-25)9-8-21-12-39-24-7-5-4-6-23(21)24/h4-7,12-13,18-20,25-28,31,39,47H,8-11,14-17H2,1-3H3,(H2,37,50)(H,38,40)(H,41,48)(H,42,51)(H,43,52)(H,44,54)(H,45,53)(H2,55,56,57)/t20-,25+,26+,27+,28-,31+/m1/s1
    Show/Hide
InChIKey
DDUIKWXPFWIAGL-OMAZYLPNSA-N
Physicochemical Property
logP
-2.3029
Rotatable Bonds
12
Heavy Atom Count
60
Polar Areas
340.36
Hydrogen Bond Donor Count
11
Hydrogen Bond Acceptor Count
12
Complexity
60

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71602897
SID: 163684126
ChEMBL ID
CHEMBL2380653
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01252, Serine/threonine-protein kinase PLK1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000050 HEK293-A Homo sapiens (Human)  1
1
IC50 = 8500 nM
   TI
   LI
   LO
   TS